Indian healthcare startup PharmEasy to acquire majority stake in listed firm Thyrocare for over $600 million

API Holdings, which operates the giant healthcare startup PharmEasy, said on Friday it has reached an agreement to acquire 66.1% stake in Thyrocare, which runs a diagnostic lab chain, for about $613 million in what is the first ever acquisition of a listed firm by an unicorn startup.

The transaction is subject to regulatory and other applicable customary approvals. Docon Technologies Pvt Ltd, a 100% subsidiary of API, will be the acquirer and shall make an open offer for an additional 26% stake, the firm said in a statement.

“We are delighted to be partnering Thyrocare. We will provide world class customer experience in diagnostics, rivalling our pharmacy experience by leveraging technology, and building on top of the massive scale & truly pan-India presence of Thyrocare. It is our aim to deliver all outpatient healthcare products & services to every Indian within 24 hours,” Siddharth Shah, CEO of API Holdings, said in a statement.

This is a developing story. More to follow…

Credit belongs to : www.techcrunch.com

You May Also Like

A security bug in health app Docket exposed COVID-19 vaccine records

A security bug in the health app Docket exposed the private information of residents vaccinated against COVID-19 in New Jersey and Utah, where the app received endorsements from state officials. Docket lets residents download and carry a digital copy of their immunizations by pulling their vaccination records from their state’s health authority. The digital copy […]
error: Content is protected !!